VANCOUVER, British Columbia, Aug. 23, 2018 (GLOBE NEWSWIRE) -- ICC Labs Inc. (“ICC Labs” or the “Company”) (TSX-V: ICC) is aware of a recent Spanish language media report speculating as to a potential transaction involving the acquisition of the Company. The policy of the Company is not to comment on rumors or speculation in the marketplace or any potential transaction unless, and until, a binding legal agreement to effect that transaction has been signed.
However, in response to a request from the Investment Industry Regulatory Organization of Canada, the Company confirms that it engages from time to time in discussions with other industry players regarding various alternatives. There can be no assurance that the Company will enter into any transaction or take any other corporate action as a result of any such discussions. ICC does not intend to make any further comment on this matter except as may be required by applicable securities laws.
ABOUT ICC LABS INC.
ICC Labs is a fully licensed producer and distributor of medicinal cannabinoid extracts, recreational cannabis and industrial hemp products in Uruguay as well as a fully licensed producer of medicinal cannabis in Colombia. The Company has active operations in Uruguay, and is focused on becoming the worldwide leading producer of cannabinoid extracts, giving support and promoting responsible use for medicinal purposes, backed by scientific research and innovation, while following strict compliance with standards for quality and safety.
For more information, please visit www.icclabs.com.